No Data
Stem Inc Cell Research Institute [Emerging Markets 5% Rule]
＜7096＞ Stem Inc. Cell Research Institute Stock Shareholding Ratio in Japan Trim 72.06% → 70.02% Reporting obligation occurrence date 2025/02/26
Express News | [Change Report] Japan Trim reports a decrease in the shareholding percentage of Stem Inc (7096.JP) to 70.02%.
The market is shrouded in uncertainty, and it's time for small material stocks to take the stage.
Amid concerns over the slowdown of the USA economy and uncertainties regarding the future of the generative Artificial Intelligence (AI) market, the Nikkei average fell below 38,000 yen for the first time in about three months on the 26th. Coupled with caution regarding Trump tariffs and the appreciation of the yen, it is difficult to venture into major stocks with high index linkages. In this context, the focus has shifted to small material stocks. Three stocks have been selected. <Stem Inc, rebounding from its record low> Stem Inc <7096.T> updated its all-time low on the 26th.
Stem Inc shares have reached a new low since the listing for several consecutive days, raising concerns about a deterioration in short-term supply and demand relations due to the share sale.
Stem Inc. <7096.T> has fallen for three consecutive days. At one point, it dropped by 59 yen to 1,126 yen, falling below its all-time low for consecutive days. After the close on the 25th, it was announced that an off-market sale would be conducted on the 26th. There seems to be concern over a deterioration in short-term supply-demand relationships. The company will conduct the sale of 210,000 shares (2.05% of the total outstanding shares excluding treasury stock) at a price of 1,150 yen per share on the 26th. The discount rate compared to the closing price of 1,185 yen on the 25th is 2.95%. The company aims to improve the distribution of its stocks and enhance liquidity.
Stem Inc Cell Research Institute, Lear, ETC.
361 Sports Japan, which is engaged in the export and import of jellybeans sporting goods, has signed a dealership contract in Japan. <4584> From the 21st, 1.5 million shares will be delivered as a result of the large exercise of the 24th subscription rights of Kids Bio (with exercise price adjustment clause). <5254> Areent has acquired additional shares of PlantStream, which develops and sells software for the plant engineering industry, and has made it a wholly-owned subsidiary. <5532> Li
StemCell Institute: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
